Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Benson Viscometers is a UK-based private medical device company that designs, develops, manufactures, and supports clinical viscometers used in laboratories, hospitals, clinics, research facilities, and universities. The company focuses on in vitro diagnostic testing of serum, plasma, whole blood, and other clinical fluids, with flagship products including the semi-automated BV1 and fully automated BV200 systems. Its instruments are used to support clinical viscosity testing and inflammatory disease assessment, particularly in settings where plasma or blood viscosity measurement informs diagnosis and monitoring. Benson Viscometers markets itself as a specialist in clinical viscometry, with products manufactured in the UK and distributed internationally. The company appears to be commercially active, FDA registered, and ISO 13485:2016 certified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Benson Viscometers.